Anna's Smart Money Dossier

_{Just facts, you think for yourself}

Insider Signals

This week, the insider activity delivered a mixed bag, with significant discretionary sales from high-flying tech names and some ambiguous “stop selling” signals that warrant a closer look. We focus on the moves that truly matter.

STEVENS MARK A, Director at NVIDIA CORP (NVDA)

• What they did: Mark A. Stevens sold $38,500,000 worth of NVDA shares this week. This was a purely discretionary sale, not part of a pre-scheduled 10b5-1 plan.

• Why it is unusual: This represents Stevens’ first significant sale in the past 90 days, after a period of no reported sales. While his overall ownership change over 90 days is a modest -2%, the sheer dollar amount and the discretionary nature of the transaction stand out. It is a substantial amount of capital being pulled off the table at a time when NVDA has seen explosive growth.

• The Action Plan: When a director at a company like NVDA decides to take $38.5 million off the table in a discretionary move, it is a signal to pay attention. If you are holding NVDA for a near-term breakout, consider tightening your stop-losses or taking some chips off the table. This is an executive signaling that, at current valuations, it is a good time to realize gains.

Junqueira Cristina Helena Zingaretti, US CEO & Chief Growth Officer at Nu Holdings Ltd. (NU)

• What they did: Cristina Helena Zingaretti Junqueira sold $4,400,000 of NU shares this week. This was another discretionary sale, indicating a deliberate decision to reduce exposure.

• Why it is unusual: This sale marks Junqueira’s first significant transaction in the past 90 days. Critically, her ownership in the company has plummeted by a staggering -54% over the same period. This is not a minor adjustment; it is an aggressive reduction in personal stake by a key executive.

• The Action Plan: A -54% ownership reduction by a US CEO and Chief Growth Officer, coupled with a $4.4 million discretionary sale, is a flashing red light. This suggests a significant lack of conviction in the company’s near-term prospects from someone deeply embedded in its operations. If you hold NU, conduct immediate due diligence on recent company performance and competitive landscape. Consider reducing your position or setting aggressive trailing stops.

Pierantoni John, Chief Accounting Officer at Grab Holdings Ltd (GRAB)

• What they did: John Pierantoni sold $53,000 worth of GRAB shares this week. Like the others, this was a discretionary transaction.

• Why it is unusual: This marks Pierantoni’s first recorded sale in the past 90 days, initiating a “Start Selling” signal. While the dollar amount is smaller than the others, a Chief Accounting Officer starting to sell, with no prior sales, can be an early indicator of internal sentiment shifting.

• The Action Plan: A “Start Selling” signal from a CAO, even for a modest amount, warrants attention. It suggests a new internal perspective on valuation or future performance. Add GRAB to your watchlist and set price alerts. Watch for any follow-through selling from other insiders in the coming weeks.

We also observed a notable pattern of “Stop Selling” signals from several major technology companies. While “Stop Selling” can sometimes be interpreted as bullish, our analysis suggests a more nuanced, and often less optimistic, interpretation in these specific cases.

HASTINGS REED, Director at NETFLIX INC (NFLX)

• What they did: Reed Hastings reported no sales this week, triggering a “Stop Selling” signal. His prior peak sale in the last 90 days was $39.8 million.

• Why it is unusual: While a “Stop Selling” signal might seem positive, it is critical to look at the context. Hastings’ ownership in NFLX has plummeted by a staggering -99% over the last 90 days. This “stop selling” does not indicate renewed bullishness; it reflects that he has largely completed his significant divestment. He is effectively almost out.

• The Action Plan: Do not misinterpret this “stop selling” as a bullish reversal. Hastings has systematically reduced his position to near zero. For all intents and purposes, his major selling is complete because there is little left to sell. This suggests a long-term shift away from NFLX as a core holding for him, not a renewed commitment.

Su Lisa T, Chair, President & CEO at ADVANCED MICRO DEVICES INC (AMD)

• What they did: Lisa T. Su reported no sales this week, triggering a “Stop Selling” signal. Her prior peak sale in the last 90 days was a substantial $26.8 million.

• Why it is unusual: Similar to Hastings, Dr. Su’s “stop selling” comes after a period of significant divestment. Her ownership change over 90 days is -4%. This pause could simply mean she has reached a temporary allocation target or is waiting for new vesting schedules. It does not automatically signal a bullish turn.

• The Action Plan: The pause in selling from Dr. Su should be viewed as a temporary lull, not a definitive reversal. Continue to monitor AMD for any actual buy signals from insiders. If you are waiting for a clear bullish signal from the C-suite, this is not it.

GRASBY PAUL DARREN, EVP & CSO at ADVANCED MICRO DEVICES INC (AMD)

• What they did: Paul Darren Grasby also reported no sales this week, triggering another “Stop Selling” signal. His prior peak sale in the last 90 days was $1.5 million.

• Why it is unusual: Grasby’s “stop selling” mirrors Dr. Su’s, following a period where his ownership decreased by -8%. The coordinated pause from two key AMD executives after recent sales suggests a synchronized approach to managing their personal holdings, rather than a sudden shift in company outlook.

• The Action Plan: The dual “stop selling” signals at AMD suggest a period of reduced insider activity rather than a strong bullish endorsement. This is a time to watch for any renewed selling or, more importantly, any buying activity from AMD insiders as a true indicator of conviction. Without buys, “stop selling” after a significant reduction is a neutral to slightly negative signal.

Bottom Line: The insider landscape this week is characterized by significant discretionary sales from leaders at top-tier tech firms like NVIDIA and Nu Holdings, signaling caution from those closest to the action. While “stop selling” signals emerged from Netflix and AMD, the context of prior massive divestments means these are not bullish reversals. Insiders are either taking profits aggressively or have largely completed their planned reductions.

Washington Watch

This week, our lobbying intelligence pipeline came up quiet. We detected no significant new lobbying momentum data, no top movers, and no rekindled issues to report from Washington.

This absence of new signals is itself a data point. It means that, for the week ending 2026-03-27, there were no dramatic shifts in reported lobbying spend or new issues emerging that triggered our anomaly detection. It does not mean D.C. is quiet; it means the new disclosures did not reveal major shifts in corporate influence campaigns.

Filing Cadence Note: As always, remember that companies showing a 100% drop in lobbying spend (e.g., the Chamber of Commerce or National Association of Realtors) are typically just between quarterly filing periods. These are not actual pullbacks in influence, but rather a reflection of the reporting schedule.

Bottom Line: The lack of new lobbying signals this week suggests a temporary equilibrium in disclosed influence efforts. Key policy battles are likely continuing behind the scenes, but without new, material shifts in reported spend. Investors should continue to monitor existing legislative and regulatory fronts, particularly those related to tech and healthcare, where policy changes can have outsized market impact.

Smart Money Dossier

This week’s Form D filings reveal a robust appetite for private capital, particularly within the biotech and broader technology sectors. However, a recurring theme is the striking absence of identifiable “smart money” pedigree, even in the largest raises. This creates a fascinating tension: significant capital is flowing, but the usual signposts of institutional conviction are largely missing.

The Headline Filing: AN2 Therapeutics, Inc. (Biotech)

• Who: The filing lists Eric Easom (Executive Officer, Director), Joshua Eizen (Executive Officer), Lucy Day (Executive Officer), Sanjay Chanda (Executive Officer), and Joseph Zakrzewski (Director) among its key personnel. While these individuals hold significant corporate titles, our deep dive did not uncover specific ‘smart money’ pedigree (e.g., serial entrepreneurs with multiple successful exits, or executives from highly influential venture funds) that would typically elevate a filing’s score.

• What: AN2 Therapeutics, Inc. is a pharmaceutical company, explicitly focused on drug discovery and development. This positions them in the high-stakes, high-reward healthcare innovation sector, where long development cycles and significant capital infusions are the norm. Their work likely involves identifying and advancing novel drug candidates through preclinical and clinical trials.

• Who’s Backing It: The filing does not disclose specific investor names or firms. This is the critical missing piece for assessing true “smart money” conviction. The capital is flowing, but the source remains opaque.

• Why It Matters: This $40,000,000 raise in equity and options is the largest and highest-scored biotech filing this week. It matters because it signifies substantial investor confidence in the pharmaceutical development sector generally, even without the explicit backing of known ‘smart money’ names. It’s a signal to watch for innovation in healthcare, but with an added layer of due diligence required on the quality of the investment given the undisclosed backers.

The Pattern

This week, the private capital markets saw significant action, with biotechnology and a broad category of “Other Technology” leading the charge in total dollars raised. However, a consistent thread across these substantial filings is the notable absence of specific, identifiable ‘smart money’ investors or executives with clear, established pedigrees.

The clustering of biotech raises, totaling over $96 million across just three top filings, underscores continued venture capital appetite for life sciences innovation. These are capital-intensive ventures, and the willingness to deploy tens of millions suggests a belief in their long-term potential.

Similarly, the “Other Technology” sector saw nearly $97 million in raises from three top filings. This broad category often captures emerging or stealthy tech plays that haven’t yet defined a clear market niche. The significant capital indicates conviction in the underlying technology or business model, even if the specifics are not public.

However, the pervasive “Not Disclosed” under “Key Investor” and the consistently moderate to low pedigree scores (ranging from 2/10 to 4/10) paint a clear picture. While capital is flowing freely, it is often from sources that do not fit the traditional “smart money” profile of Tier-1 VCs or serial entrepreneurs with a proven track record. This suggests a broader, perhaps less discerning, deployment of capital in the private markets.

Froth Watch

This week’s Form D filings presented several instances where substantial capital raises were noted, but the lack of specific detail or identifiable pedigree suggests caution. When the “smart money” isn’t clearly visible, it’s wise to be skeptical.

• Alacriti Payments Inc. ($50.0M): This significant raise in Fintech is notable for its size, but the complete absence of identifiable executive or investor pedigree means this capital infusion lacks the usual ‘smart money’ endorsement. It’s a large sum without a clear backer to vouch for its strategic importance.

• Steno Agency, Inc. ($48.9M): A nearly $49 million equity raise in an entirely unspecified sector, with no identifiable executive or investor pedigree. This is a low-signal filing where the substantial capital deployed doesn’t come with any clear indication of ‘smart money’ conviction or even a clear business model.

• STIPFI RP LLC ($37.6M): This nearly $38 million equity raise in “business services” with no specific offerings detailed and no identifiable pedigree for executives or investors. The “RP” hints at real property, suggesting a real estate play, but the lack of transparency is a concern.

• GIBO HOLDINGS Ltd ($39.0M), ViaVia Corp ($30.1M), Atana Elements Inc ($27.5M): These three “Other Technology” raises total over $96 million. While the sector is attractive, the consistent lack of specific company focus and identifiable ‘smart money’ pedigree across all three raises suggests broad capital deployment without the focused conviction typically seen from top-tier backers.

• Tectonic Metals Inc. ($35.1M): A substantial $35 million equity raise in the metals/mining sector, but again, no specific executive or investor pedigree is disclosed. While the sector can be capital-intensive, the lack of named ‘smart money’ means this is a “follow the money, but verify the source” situation.

The Fine Print

Not all signals are created equal. Our job is to cut through the noise and highlight what genuinely moves the needle for our readers. This week’s data came with its own set of nuances and complications.

• NVIDIA’s Stevens Mark A’s $38.5 million sale was discretionary, making it a high-conviction signal. It was not a routine 10b5-1 plan or a sell-to-cover, but a deliberate decision to reduce exposure at current levels.

• Nu Holdings’ Cristina Helena Zingaretti Junqueira’s $4.4 million sale was also discretionary and highly significant due to the dramatic -54% reduction in her ownership stake. This is a strong signal of changing sentiment from a top executive.

• Grab Holdings’ Pierantoni John’s $53,000 discretionary “Start Selling” signal, while smaller in dollar amount, is still noteworthy. A Chief Accounting Officer starting to sell is an initial signal that bears watching for follow-through.

• The “Stop Selling” signals for Netflix’s Reed Hastings and AMD’s Lisa T. Su and Paul Darren Grasby are misleading if taken at face value. In Hastings’ case, his -99% ownership change means he simply has almost no shares left to sell. For AMD executives, these pauses likely reflect a temporary lull after significant prior sales, not a sudden bullish shift. Do not confuse a lack of selling with a renewed conviction to buy.

• In our Form D analysis, the most pervasive complication was the lack of identifiable executive or investor pedigree across numerous high-value raises. Even for filings scored 3/10 or 4/10, the detailed dossiers often stated “No specific pedigree information was found.” This means that while hundreds of millions are flowing into private companies, the traditional ‘smart money’ signals are often absent, demanding greater scrutiny of the underlying business and its true backers.

What We’re Watching

Looking ahead, we are keeping a close eye on several fronts where this week’s data points could evolve into actionable trends.

• Biotech and “Other Technology” Momentum: The consistent, large capital raises in these sectors via Form D filings suggest venture capital remains hungry for innovation. We will be tracking if specific ‘smart money’ names start to emerge in these areas, lending more credibility to the capital flows.

• Tech Insider Follow-Through: Will the significant discretionary sale from NVIDIA’s Mark A. Stevens trigger similar profit-taking from other executives in the semiconductor space? We are setting alerts for additional sales from NVDA and its peers.

• Fintech Executive Conviction: The aggressive selling by Nu Holdings’ Cristina Helena Zingaretti Junqueira raises questions about the near-term outlook for the fintech sector. We will monitor for any further insider activity at NU and other fast-growing fintech players to gauge broader sentiment.

• Lobbying Re-engagement: Despite a quiet week in new lobbying disclosures, D.C. always has active policy discussions. We are anticipating new filings to reveal renewed focus on AI regulation, healthcare pricing, and critical mineral supply chains in the coming weeks.

We will continue to track these crucial signals, ensuring you have the unfair information edge you need to navigate these markets. Be prepared for next week’s briefing.

-Daybreak Intelligence Desk